Airway inflammation in employees involved in cultivating Japanese mushrooms (bunashimeji)

Kenji Tsushima1, Masanori Yasuo, Tsuyoshi Tanabe

  • 1Department of Internal Medicine, Shinshu University School of Medicine, Asahi Matsumoto, Japan. tsushima@hsp.md.shinshu-u.ac.jp

Respirology (Carlton, Vic.)
|April 16, 2008
PubMed
Abstract

Insights

Bunashimeji spores cause airway inflammation and toxic effects in the lungs. This study found direct inflammatory impacts on bronchial epithelial cells, leading to respiratory symptoms like cough and sputum.

Area of Science:

  • Pulmonology
  • Immunology
  • Toxicology

Background:

  • Chronic inhalation of spores can lead to respiratory issues, including productive cough and sputum.
  • Bunashimeji spores are a potential trigger for airway inflammation.

Purpose of the Study:

  • To determine the clinical pathophysiology of airway inflammation induced by bunashimeji spores.
  • To investigate the direct toxic inflammatory effects of bunashimeji spores on the airways.

Main Methods:

  • Enrolled sensitized and non-sensitized employees with respiratory symptoms.
  • Conducted sputum induction and high-resolution computed tomography (HRCT).
  • Assessed in vitro effects of bunashimeji spores on human bronchial epithelial cells and measured inflammatory markers (IL-8, ENA-78).

Main Results:

  • Elevated neutrophil counts in sputum correlated with abnormal HRCT findings.
  • Bunashimeji spore stimulation significantly increased IL-8 and ENA-78 concentrations and IL-8 mRNA expression in bronchial epithelial cells.
  • Higher spore concentrations led to increased IL-8 mRNA expression over time.

Conclusions:

  • Bunashimeji spore inhalation directly causes toxic inflammatory effects in the airways.
  • These inflammatory effects are independent of the individual's sensitization level.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...